About this Book

The increasing incidence of disease, especially in developed and developing countries, demands the evaluation of potential unexplored pharmaceutic resources and releases. The pharmaceutical industry has historically provided innovative therapeutic solutions to different medical conditions, through biological and biosimilar medicines with pharmaceutical potential, which may include monoclonal antibodies, cytokines, growth factors hormones, enzymes, vaccines, or blood products. However, due to pharmaceutical spending accounts for a large share of health spending worldwide, and the increasing demand for chemical diversity in pharmaceutical screening programs, and their benefits in terms of increasing life expectancy and improving quality of life, identifying novel therapeutic drug technology is an exciting approach.